GLP-1 Receptor Agonist

How common are Ozempic side effects?

Direct Answer

The most frequent side effects of Ozempic are gastrointestinal: nausea (up to 20%), diarrhea (8-9%), vomiting (5-9%), and constipation (3-5%). These are most intense during the first 4-8 weeks as the dose is increased, and they improve for most people as the body adjusts. Serious side effects like pancreatitis are rare (less than 1%). The side effects are a direct result of how the drug works, slowing stomach emptying is what causes both the appetite suppression and the nausea.

Based on published clinical trial data and FDA prescribing information. This is not medical advice - always consult your healthcare provider.

Supporting Evidence

Side Effects

Nausea20%
Diarrhea15%
Vomiting10%
Constipation11%
Stomach pain / cramping9%

Serious (rare)

  • Pancreatitis (<1%)
  • Kidney failure
  • Gallbladder disease

Clinical Trials

Expected HbA1c reduction: −1.5% to −1.8% from baseline (SUSTAIN trials, 0.5–2mg). Weight loss: −9–14 lbs. Wegovy (2.4mg/wk): −14.9% body weight (STEP-1). Lifestyle comparison: dietary intervention alone reduces diabetes risk by 58% (DPP trial). Oral semaglutide (OW3 9mg): −1.5–1.7% HbA1c in phase 3 trials.

Funding transparency: STEP trials and most published semaglutide research were funded by Novo Nordisk, which reported approximately $38.6B in semaglutide revenue in 2023. Lead investigators received advisory board fees, co See full funding details

Read the complete Ozempic® / Wegovy® / Rybelsus® guide

Side effect rates, clinical trial data, funding transparency, drug interactions, tapering protocols, and lifestyle alternatives - all in one place.

View Ozempic® / Wegovy® / Rybelsus®